-
-
-
-
-
-
-
CEA Industries sees opportunity in FDA authorization of JUUL products
-
-
-
-
-
-
-
Precision BioSciences gets FDA orphan drug designations for DMD treatment
-
-
-
-
-
-
-
DiaMedica reports positive interim results from preeclampsia trial
-
-
-
-
-
-
-
Innovent Biologics' cancer drug shows promise in phase 1 trial
-
-
-
-
-
-
-
Tempus receives FDA clearance for heart condition detection software
-
-
-
-
-
-
-
MiNK Therapeutics publishes research on iNKT cell therapy platform
-
-
-
-
-
-
-
Primary Hydrogen begins phase 2 sampling at three BC hydrogen projects
-
71,222 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.